Genomic alterations are associated with response to aromatase inhibitor therapy for ER-positive postmenopausal ductal carcinoma in situ: (CALGB 40903, Alliance).

Detalles Bibliográficos
Publicado en:	Breast Cancer Research Vol. 27; no. 1; pp. 1 - 12
Autores principales:	Marks, Jeffrey R., Zhang, Dadong, Hardman, Timothy, Chen, Yunn-yi, Hall, Allison, Simpson, Lunden, Hieken, Tina, Bedrosian, Isabelle, Price, Elissa, Sheng, Jeff, Dai, Yanwan, Lee, Marissa, Sibley, Alexander B., Owzar, Kouros, Hwang, E. Shelley
Formato:	Journal Article
Publicado:	BioMed Central 2/20/2025
Acceso en línea:	Ver este registro en EBSCOhost

Descripción
Descripción no disponible.